July 23, 2013
Kyowa Hakko Kirin announced on July 19 that it filed for an additional indication on the same day for untreated CCR4-positive adult T-cell leukemia-lymphoma (ATL), relapsed CCR4-positive peripheral T-cell lymphoma (PTCL), and cutaneous T-cell lymphoma (CTCL) for its molecular-targeted treatment...read more